The National Comprehensive Cancer Network prostate cancer guideline recommends genetic counseling for patients with prostate cancer and having BRCA1/2, ATM, PALB2, or FANCA mutation [13]. This evidence concerns the gene BRCA1 and prostate carcinoma.